Top Markets
Coin of the day
PharmaBlock Sciences (Nanjing), Inc. PharmaBlock Sciences (Nanjing), Inc.

PharmaBlock Sciences (Nanjing), Inc.

300725
Peringkat dalam Saham #7576
PharmaBlock Sciences (Nanjing), Inc. delivers a comprehensive suite of chemical... PharmaBlock Sciences (Nanjing), Inc. delivers a comprehensive suite of chemical products and specialized services, supporting the pharmaceutical industry across the full spectrum of its operations – from initial research and development phases to large-scale commercial production. The company's primary offerings encompass: A vast inventory of chemical building blocks, available for supply at every stage of drug creation, from early discovery through to advanced development and commercial manufacturing. The creation of diverse chemical libraries, derived from their building blocks, specifically designed to accelerate drug discovery processes. Contract development and manufacturing (CDMO) services for essential pharmaceutical components, including raw starting materials (RSMs), chemical intermediates, active pharmaceutical ingredients (APIs), and finished drug products, catering to both clinical development programs and market demands. Established in 2006, PharmaBlock Sciences maintains its corporate headquarters in Nanjing, People's Republic of China.
Harga Saham
$6.59
Kapitalisasi Pasar
$1.54B
Perubahan (1 hari)
-2.84%
Perubahan (1 tahun)
9.06%
Negara
CN
Perdagangan PharmaBlock Sciences (Nanjing), Inc. (300725)

Kategori

Laba untuk PharmaBlock Sciences (Nanjing), Inc. (300725)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari PharmaBlock Sciences (Nanjing), Inc., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk PharmaBlock Sciences (Nanjing), Inc. dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing